Atlas Trials

68 Gallium-Fibroblast Activating Protein Inhibitors-46 Positron Emission Tomography - Computerized Tomography for Molecular Assessment of Fibroblast Activation and Risk Assessment in Solid Tumors

Clinical trial NCT06136065 · UNKNOWN

Trial details

NCT number
NCT06136065
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Solid Tumor, Unspecified, Adult
Start date
2023-08-21
Primary completion
2025-08-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.